New York
(MMD Newswire) — Nanotronics Imaging, a pioneer in nano-inspection for
semiconductors, announced today that it will assist medical research by
applying its groundbreaking inspection methods to neuroscience, regenerative
medicine and other life science fields. Its inaugural partners are the Joseph
L. Mailman School of Public Health at Columbia
University Medical
Center, and the McGowen Institute at University of Pittsburgh. Both institutions have begun
to make promising strides with Nanotronics’ systems in Alzheimer’s research and
large-scale regenerative medicine.
“One of the major challenges for scientific research is
to have the ability to rapidly screen materials at the nanoscale, and in no
field is that more critical than life-saving medical research,” said
Nanotronics Imaging CEO and founder Dr. Matthew Putman. “Scientists
recently discovered, for example, that Alzheimer’s disease is not irreversible.
Rapid high-resolution imaging of the brain’s neurons will be critical to furthering
such medical advances, as well as in the study of other debilitating diseases
such as schizophrenia. Our high resolution nSPEC® microscope has unparalleled
high-area capabilities, covering large areas of the brain, and can reduce
imaging time from weeks down to days or even minutes.”
Nanotronics Imaging combines a mature technology, the
optical microscope, with leading-edge proprietary software, to create
fully-automated systems for rapid wide-field inspection of features at the
nanometer scale. Nanotronics’ technology has been used to create maps of
defects and features on semiconductor substrate wafers and to automatically
identify and catalog them at a fraction of the cost of any other wafer
inspection instrumentation. While the company has achieved significant traction
in this market (with applications for LEDs and RF Amplifiers for mobile
devices) its patented technology can be applied to many other areas, as
evidenced by its welcome foray into the medical field.
About Nanotronics Imaging
Nanotronics Imaging was founded in Akron, Ohio in 2008 by Dr. Matthew Putman
and John Putman after selling their previous international instrument business,
25 year old Tech Pro, Inc. to Roper Industries, an S&P 500 company.
Nanotronics Imaging’s first product, nSPEC®, a semiconductor analysis system,
was just released in May of 2011 and is already being sold across three
continents. Dr. Matthew Putman, CEO of Nanotronics Imaging, lives in New York, has a PhD in applied physics and is also on the
faculty of Columbia
University. For more on
Nanotronics Imaging go to www.nanotronicsimaging.com.
Posted by Sean Fenske, Editor-in-Chief, MDT
